Corporate ActionAug 6, 2026, 07:56 PM
BlossomHill Therapeutics Increases Share Offering by 1.8M Shares
AI Summary
BlossomHill Therapeutics, Inc. filed an S-1MEF registration statement on August 6, 2026, to increase the aggregate number of common stock shares offered and registered. The company added 1,796,875 shares, including 234,375 shares subject to the underwriters' option. This filing is a post-effective amendment to an earlier S-1 registration statement (File No. 333-297512) and was made pursuant to Rule 462(b) of the Securities Act.
Key Highlights
- BlossomHill Therapeutics increased common stock offering by 1,796,875 shares.
- 234,375 shares are subject to underwriters' option to purchase additional shares.
- Filing is a post-effective amendment under Rule 462(b) of the Securities Act.
- References earlier Registration Statement on Form S-1 (File No. 333-297512).
- Additional shares are no more than 20% of the earlier offering's maximum aggregate price.
Price Impact
More from BLSM